phorbol 12,13-dibutyrate has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, M; Minoguchi, K; Oda, N; Ohta, S; Okada, S; Samson, KT; Tanaka, A; Watanabe, Y; Yamamoto, M; Yamamoto, Y; Yokoe, T | 1 |
1 other study(ies) available for phorbol 12,13-dibutyrate and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
Effect of fluvastatin on apoptosis in human CD4+ T cells.
Topics: Antibodies; Apoptosis; bcl-2-Associated X Protein; Caspases; CD3 Complex; CD4-Positive T-Lymphocytes; Cells, Cultured; Cytochromes c; Down-Regulation; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Ionomycin; Lymphocyte Activation; Phorbol 12,13-Dibutyrate; Proto-Oncogene Proteins c-bcl-2 | 2005 |